1149 related articles for article (PubMed ID: 8300928)
1. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
[TBL] [Abstract][Full Text] [Related]
2. Skin cancer in the PUVA-48 cooperative study.
Roenigk HH; Caro WA
J Am Acad Dermatol; 1981 Mar; 4(3):319-24. PubMed ID: 7217399
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC
Toxicol Pathol; 2005; 33(2):292-9. PubMed ID: 15902973
[TBL] [Abstract][Full Text] [Related]
4. Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers.
Harwood CA; Spink PJ; Surentheran T; Leigh IM; Hawke JL; Proby CM; Breuer J; McGregor JM
J Invest Dermatol; 1998 Jul; 111(1):123-7. PubMed ID: 9665398
[TBL] [Abstract][Full Text] [Related]
5. PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer.
van Praag MC; Bavinck JN; Bergman W; Rosendaal FR; Mommaas AM; Bruynzeel I; Scheffer E; Vermeer BJ; Bruijn JA
J Am Acad Dermatol; 1993 Mar; 28(3):412-7. PubMed ID: 8445056
[TBL] [Abstract][Full Text] [Related]
6. Skin carcinomas and treatment with photochemotherapy (PUVA).
Lindskov R
Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
[TBL] [Abstract][Full Text] [Related]
7. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients.
Lever LR; Farr PM
Br J Dermatol; 1994 Aug; 131(2):215-9. PubMed ID: 7917985
[TBL] [Abstract][Full Text] [Related]
8. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
[TBL] [Abstract][Full Text] [Related]
9. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
Buckley DA; Rogers S
Clin Exp Dermatol; 1996 Jan; 21(1):43-5. PubMed ID: 8689768
[TBL] [Abstract][Full Text] [Related]
10. Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients.
Zumtobel U; Schwarze HP; Favre M; Taïeb A; Delaunay M
Dermatology; 2001; 202(2):127-30. PubMed ID: 11306834
[TBL] [Abstract][Full Text] [Related]
11. p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).
Nataraj AJ; Wolf P; Cerroni L; Ananthaswamy HN
J Invest Dermatol; 1997 Aug; 109(2):238-43. PubMed ID: 9242514
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
[TBL] [Abstract][Full Text] [Related]
13. PUVA treatment and skin cancer: A follow-up study.
Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
[TBL] [Abstract][Full Text] [Related]
14. UV-related skin conditions and Langerhans' cell populations in human skin.
Bergfelt L
Acta Derm Venereol; 1993 Jun; 73(3):194-6. PubMed ID: 8105617
[TBL] [Abstract][Full Text] [Related]
15. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
16. p53 tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients.
Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):924-31. PubMed ID: 9204056
[TBL] [Abstract][Full Text] [Related]
17. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous neoplasia following PUVA therapy for psoriasis.
McKenna KE; Patterson CC; Handley J; McGinn S; Allen G
Br J Dermatol; 1996 Apr; 134(4):639-42. PubMed ID: 8733363
[TBL] [Abstract][Full Text] [Related]
19. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Kerl H; Wolf P
Photochem Photobiol; 2001 Aug; 74(2):323-30. PubMed ID: 11547572
[TBL] [Abstract][Full Text] [Related]
20. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Stern RS; Liebman EJ; Väkevä L
J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]